Eye on the Ball

Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.

GSK breaks industry ranks to improve access to medicines

17 Feb – Pharmaceutical giant GlaxoSmithKline should be congratulated for breaking industry ranks and taking a major step toward helping poor people in developing countries to get better access to medicines, says international agency Oxfam. However GSK’s initiative this week is just the beginning.
Subscribe to RSS - TRIPS